Madrigal Pharmaceuticals Inc
(MDGL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,779 | -15,080 | -32,811 | -21,336 | -12,824 |
| Depreciation Amortization | 56 | 28 | 96 | 71 | 47 |
| Accounts payable and accrued liabilities | -2,041 | 1,889 | 558 | -898 | -1,341 |
| Other Working Capital | 2,928 | 2,552 | -6,281 | -6,347 | -4,621 |
| Other Operating Activity | 15,818 | 4,133 | 12,931 | 9,268 | 4,735 |
| Operating Cash Flow | $-18,018 | $-6,478 | $-25,507 | $-19,242 | $-14,004 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 32,987 | -3,450 | -380,054 | -405,050 | -183,035 |
| PPE Investments | -40 | -41 | -22 | -14 | -1 |
| Investing Cash Flow | $32,947 | $-3,491 | $-380,076 | $-405,064 | $-183,036 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 200 | 83 | 314,335 | 313,725 | 313,274 |
| Financing Cash Flow | $200 | $83 | $314,335 | $313,725 | $313,274 |
| Beginning Cash Position | 57,379 | 57,379 | 148,627 | 148,627 | 148,627 |
| End Cash Position | 72,508 | 47,493 | 57,379 | 38,046 | 264,861 |
| Net Cash Flow | $15,129 | $-9,886 | $-91,248 | $-110,581 | $116,234 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,018 | -6,478 | -25,507 | -19,242 | -14,004 |
| Capital Expenditure | -40 | -41 | -22 | -14 | -1 |
| Free Cash Flow | -18,058 | -6,519 | -25,529 | -19,256 | -14,005 |